Hyman Scott, MD, MPH is the Clinical Research Medical Director at Bridge HIV in the San Francisco Department of Public Health (SFDPH) and an Assistant Clinical Professor of Medicine at UCSF. His research focuses on implementation of HIV and STI prevention clinical trials, understanding racial/ethnic disparities in HIV acquisition, and using technology to expand uptake and use of HIV prevention interventions. He is active with several research networks including the HIV Vaccine Network (HVTN), HIV Prevention Trials Network (HPTN), and Adolescent Trials Network (ATN).

Dr. Scott completed his B.S. in Biology at Stanford University, his M.D. at Yale School of Medicine, and his M.P.H from University of California, Berkeley. He completed his residence, chief residency, Infectious Disease fellowship, and post-doctoral fellowship training at UCSF. He is currently an HIV and PrEP provider at the Positive Health Program (Ward 86) at UCSF, and serves as Medical Director for the San Francisco AIDS Foundation, one of the largest PrEP and DoxyPEP providers in the Northern California. He was listed in the 2025 Time Health100 list of the world’s most influential people for his work on STI prevention.